Gritstone Bio
Biotechnology, 5959 Horton St Ste 300, Emeryville, California, 94608, United States, 201-500 Employees
Phone Number: 51********
Who is GRITSTONE BIO
Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors ...
Read More
-
Headquarters: 5959 Horton St Ste 300, Emeryville, California, 94608, United States
-
Date Founded: 2015
-
Employees: 201-500
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
Does something look wrong? Fix it. | View contact records from GRITSTONE BIO
Gritstone bio Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Gritstone bio
Answer: Gritstone bio's headquarters are located at 5959 Horton St Ste 300, Emeryville, California, 94608, United States
Answer: Gritstone bio's phone number is 51********
Answer: Gritstone bio's official website is https://gritstonebio.com
Answer: Gritstone bio's revenue is $10 Million to $25 Million
Answer: Gritstone bio's SIC: 2836
Answer: Gritstone bio has 201-500 employees
Answer: Gritstone bio is in Biotechnology
Answer: Gritstone bio contact info: Phone number: 51******** Website: https://gritstonebio.com
Answer: Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune systems ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and more recently extended our programs to include viral antigens displayed on the surface of virus-infected cells. The biology underlying immune system recognition of targets on the surface of abnormal cells is common to both anti-tumor and anti-viral immunity. Consequently, we believe that activating and directing the immune system to these targets could offer an important opportunity to extend the benefits of immunotherapy for more patients.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month